| pubmed-article:3225773 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C1123023 | lld:lifeskim |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C0025924 | lld:lifeskim |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C1956050 | lld:lifeskim |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C0006629 | lld:lifeskim |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C0700468 | lld:lifeskim |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C0064683 | lld:lifeskim |
| pubmed-article:3225773 | lifeskim:mentions | umls-concept:C0104857 | lld:lifeskim |
| pubmed-article:3225773 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:3225773 | pubmed:dateCreated | 1989-3-29 | lld:pubmed |
| pubmed-article:3225773 | pubmed:abstractText | The effect of 1-dodecylhexahydro-2H-azepine-2-one (Azone; laurocapran; 1) on the permeation of verapamil hydrochloride (2) through rat skin was studied. Compound 1 was used in various concentrations in the donor phase. The permeation of the drug increased significantly in the presence of 1 and the enhancement in permeation was dependent on the concentration of 1. A comparison of the enhancing effect of 3% 1 on permeation of 2 through rat, hairless mouse, and human cadaver skin was made. Compound 1 altered the permeability of hairless mouse skin significantly, whereas the effect on rat and human skin was comparable and not very drastic. | lld:pubmed |
| pubmed-article:3225773 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3225773 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225773 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3225773 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225773 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225773 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3225773 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3225773 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:3225773 | pubmed:issn | 0022-3549 | lld:pubmed |
| pubmed-article:3225773 | pubmed:author | pubmed-author:RitschelW AWA | lld:pubmed |
| pubmed-article:3225773 | pubmed:author | pubmed-author:AgrawalaPP | lld:pubmed |
| pubmed-article:3225773 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3225773 | pubmed:volume | 77 | lld:pubmed |
| pubmed-article:3225773 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3225773 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3225773 | pubmed:pagination | 776-8 | lld:pubmed |
| pubmed-article:3225773 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:meshHeading | pubmed-meshheading:3225773-... | lld:pubmed |
| pubmed-article:3225773 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3225773 | pubmed:articleTitle | Influence of 1-dodecylhexahydro-2H-azepin-2-one (Azone) on the in vitro permeation of verapamil hydrochloride across rat, hairless mouse, and human cadaver skin. | lld:pubmed |
| pubmed-article:3225773 | pubmed:affiliation | Division of Pharmaceutics and Drug Delivery Systems, College of Pharmacy, University of Cincinnati Medical Center, OH 45267-0004. | lld:pubmed |
| pubmed-article:3225773 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3225773 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3225773 | pubmed:publicationType | In Vitro | lld:pubmed |
